Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder



Status:Completed
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:8/15/2018
Start Date:May 2012
End Date:May 2014

Use our guide to learn which trials are right for you!

A Placebo-Controlled, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Efficacy and Safety of TBS-2 Intranasal Testosterone Gel in Women With Acquired Female Orgasmic Disorder

The purpose of this study is to assess and compare the effects of 3 dose strengths of TBS-2
intranasal testosterone gel to placebo on the occurrence of orgasm.


Inclusion Criteria

Subjects who meet the following criteria may be included in the study:

At Visit 1:≤

- Be a generally healthy female aged 18 years and older, inclusive, who has no physical
impediment to sexual function

- Have a diagnosis of acquired female orgasmic disorder defined as absence of orgasm
during the past 6 months and according to the Diagnostic and Statistical Manual of
Mental Disorders IV (DSM-IV) criteria. Subtype should be generalized and not due to
etiological factors that would be unlikely to be related to hormone function (eg,
depression, relationship discord, alcoholism, surgery, injury). Hypoactive sexual
desire disorder as a co-morbid disorder is allowed only if it began after the female
orgasmic disorder diagnosis;

- Have a score of >15 with a score of ≥2 for question #15 on the FSDS DAO at Screening
Visit;

- Be a sexually active, hetero- or homosexual woman in a steady relationship for at
least 6 months and agree to have at least 4 sexual events over 28-day period of time.
The subject's partner should not have any untreated sexual dysfunctions;

- Be on a reliable birth control method (ie, stable systemic hormonal contraception for
the whole duration of the study and 30 days after study completion [for at least 3
months prior to study], IUD, barrier method) or not engaging in heterosexual
intercourse. Birth control method used by subject at screening is not to be changed
during the course of the study;

- Have a normal ENT examination;

- Have a body mass index ≤35;

- Have a clinically acceptable pelvic examination and Pap smear as read by a licensed
laboratory facility (no evidence of malignancy) within the 2 years prior to
Randomization;

- Have a clinically acceptable mammogram;

- Be able to complete a web-based questionnaire within 24 hours of each sexual event;

- Be able to read English and provide written informed consent; and

At Visit 2:

- Have at least 4 sexual events and an absence of orgasm during the 28 day
Screening/Baseline Period as determined by MONASH WHP FSSQ.

Exclusion Criteria

Subjects who meet any of the following criteria will not be eligible to participate in the
study:

- Have a known history of hypersensitivity to testosterone or any component of the study
drug;

- Have a history of any clinically relevant psychiatric disorder that could impact
sexual functioning, contribute to increased risk for patient safety, or significantly
compromise participation in the study (eg, bipolar disorders, psychotic disorders,
severe anxiety, eating disorders, borderline personality disorder, untreated Major
Depressive Disorder);

- Have a score of ≥14 on the Beck Depression Inventory II at Screening Visit. Subjects
with a score of ≥14 and ≤19 at Screening may be eligible to participate in the study
if a specialist (psychologist or psychiatrist) concludes that the subject is not
clinically depressed;

- Have other concurrent female sexual dysfunction disorders as defined by DSM-IV
criteria, eg, Sexual Aversion Disorder, Substance-Induced sexual dysfunction,
dyspareunia (not caused by inadequate foreplay stimulation or alleviated by
lubricants), vaginismus, Gender Identity Disorder, paraphilia, or sexual dysfunction
due to a general medical condition;

- Be experiencing relational discord;

- Have a history of dementia or other neurodegenerative diseases, organic brain disease,
stroke, transient ischemic attacks, brain surgery, significant brain trauma, multiple
sclerosis, spinal cord injury, peripheral neuropathy, and epilepsy (febrile seizures
limited to childhood do not exclude patients);

- Be currently receiving treatment with selective norepinephrine reuptake inhibitors
(SNRIs) and selective serotonin reuptake inhibitors (SSRIs) and/or medications that
interfere with the metabolism of testosterone (eg, anastrozole, clomiphene,
testolactone, ketoconazole, spironolactone, histamine 2 [H2 receptor blockers, etc.]);

- Have a history of, or current evidence of, abuse of alcohol or any drug substance,
licit or illicit, or be a regular drinker of more than 3 units of alcohol daily (1
unit = 300 mL beer, 1 glass wine, 1 measure spirit);

- Have a history of cancer other than nonmelanotic skin cancer;

- Have a history of deep venous thrombosis or coagulation disorders;

- Have a significant medical condition (eg, hepatic, renal cardiovascular, endocrine
including diabetes mellitus). Subjects with treated hypertension, treated
hyperlipidemia, or treated thyroid disease will not be excluded provided they have
been on stable therapy for at least 3 months;

- Had any major surgical procedure within the past 6 months including hysterectomy,
hysterectomy with bilateral salpingo oophorectomy, or vaginal incontinence surgery

- Are receiving treatment with systemic glucocorticosteroids, sex steroid hormones such
as androgens (eg, dehydroepiandrosterone [DHEA]) or gestagens (eg, anabolic steroids)
and using any post menopausal hormone therapy;

- Have a history of severe or multiple drug allergies, severe adverse drug reaction or
drug-related leucopenia;

- Have a history of nasal disorders (eg, atrophic rhinitis, polyposis, abuse of nasal
decongestants, clinically relevant nasal septum deviation, recurrent epistaxis), sinus
disease or nasal surgery and/or seasonal or perennial allergic rhinitis in the active
phase;

- Be using any form of chronic intranasal medication delivery, specifically nasal
corticosteroids or decongestants;

- Have a diagnosis of sleep apnea and be using a continuous positive airway
pressure/automatic positive airway device;

- Have a history of diagnosed hirsutism, alopecia or clinically significant acne;

- Have a history of diagnosed polycystic ovarian syndrome;

- Have pelvic inflammatory disease, chronic urinary tract, vaginal, or cervical
infections, interstitial cystitis, vulvodynia, or significant symptomatic vaginal
atrophy;

- Are currently pregnant, by history or positive serum pregnancy test at Screening Visit
or have been pregnant within the 12 months prior to Screening Visit;

- Is breast feeding or have breast fed within the 6 months prior to Screening Visit;

- Are positive for hepatitis B-surface antigen, hepatitis C, or Human Immunodeficiency
Virus (HIV);

- Have abnormal thyroid stimulating hormone level;

- For pre-menopausal women, have SHBG value <18 86 nmol/L; For post-menopausal women,
have SHBG value >160 nmol/L

- Have any medical or psychiatric condition, physical examination finding, or laboratory
result which, in the opinion of the principal investigator, would put the subject at
additional medical risk or make her unlikely to be able to comply with study
requirements; or

- Have received any drug as part of a research study within 30 days prior to the
Screening Visit.
We found this trial at
44
sites
303 Williams Ave
Huntsville, Alabama 35801
256-533-6603
?
mi
from
Huntsville, AL
Click here to add this to my saved trials
4110 Center Point Dr.
Fort Myers, Florida 33916
239-936-4421
?
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Akron, Ohio 44311
?
mi
from
Akron, OH
Click here to add this to my saved trials
?
mi
from
Beachwood, OH
Click here to add this to my saved trials
Billings, Montana 59102
?
mi
from
Billings, MT
Click here to add this to my saved trials
Bingham Farms, Michigan 48025
?
mi
from
Bingham Farms, MI
Click here to add this to my saved trials
Birmingham, Alabama 35209
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Champaign, Illinois 61820
?
mi
from
Champaign, IL
Click here to add this to my saved trials
Chandler, Arizona 85225
?
mi
from
Chandler, AZ
Click here to add this to my saved trials
?
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Chicago, Illinois 60654
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Clearwater, Florida 33761
?
mi
from
Clearwater, FL
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
801 Monterey Street
Coral Gables, Florida 33134
?
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Dallas, Texas 75231
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Denver, Colorado 80218
?
mi
from
Denver, CO
Click here to add this to my saved trials
Denver, Colorado 80239
?
mi
from
Denver, CO
Click here to add this to my saved trials
Edina, Minnesota 55435
?
mi
from
Edina, MN
Click here to add this to my saved trials
Fargo, North Dakota 58103
?
mi
from
Fargo, ND
Click here to add this to my saved trials
Groton, Connecticut 06340
?
mi
from
Groton, CT
Click here to add this to my saved trials
Hartford, Connecticut 06117
?
mi
from
Hartford, CT
Click here to add this to my saved trials
Jacksonville, Florida 32209
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Lincoln, Nebraska 68510
?
mi
from
Lincoln, NE
Click here to add this to my saved trials
Lutherville, Maryland 21093
?
mi
from
Lutherville, MD
Click here to add this to my saved trials
Mayfield Heights, Ohio 44124
?
mi
from
Mayfield Heights, OH
Click here to add this to my saved trials
Melbourne, 3800
?
mi
from
Melbourne,
Click here to add this to my saved trials
Midlothian, Virginia 23114
?
mi
from
Midlothian, VA
Click here to add this to my saved trials
Nashville, Tennessee 37203
?
mi
from
Nashville, TN
Click here to add this to my saved trials
617 West 168th Street
New York, New York 10032
?
mi
from
New York, NY
Click here to add this to my saved trials
Norfolk, Virginia 23502
?
mi
from
Norfolk, VA
Click here to add this to my saved trials
Overland Park, Kansas 66202
?
mi
from
Overland Park, KS
Click here to add this to my saved trials
Oviedo, Florida 32765
?
mi
from
Oviedo, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19114
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
3100 Duraleigh Rd
Raleigh, North Carolina 27612
(919) 781-2514
Wake Research Associates, LLC Wake Research is an Organization of Unified Investigational Sites working closely...
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Roswell, Georgia 30075
?
mi
from
Roswell, GA
Click here to add this to my saved trials
Round Rock, Texas 78681
?
mi
from
Round Rock, TX
Click here to add this to my saved trials
San Antonio, Texas
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
San Diego, California 92120
?
mi
from
San Diego, CA
Click here to add this to my saved trials
San Diego, California 92108
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Seattle, Washington 98105
?
mi
from
Seattle, WA
Click here to add this to my saved trials
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
?
mi
from
West Chester, OH
Click here to add this to my saved trials
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials